HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thioredoxin-interacting protein suppresses bladder carcinogenesis.

Abstract
Thioredoxin-interacting protein (TXNIP), which has a tumor-suppressive function, is underexpressed in some human cancers. The function of TXNIP in vivo in carcinogenesis is not fully understood. Here, we show TXNIP to be downregulated in human bladder cancer according to grade and stage and also that loss of TXNIP expression facilitates bladder carcinogenesis using a mouse bladder cancer model. N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN)-induced bladder cancer was found in 100% of Txnip knockout (KO) mice at week 8 of 0.025% BBN administration but in only 22% of wild-type (WT) mice at the same point. Among growth stimulators, phospho-extracellular signal-regulated kinase (pERK) expression was stronger during bladder carcinogenesis in Txnip-KO mice than in WT mice. We then evaluated TXNIP's effects on ERK activation through various growth stimulators and their receptors. Overexpression of TXNIP in human bladder cancer cells attenuated pERK expression upon stimulation with stromal cell-derived factor-1 (SDF-1) but not with epidermal growth factor or insulin-like growth factor-1. In Txnip-KO mice, immunohistochemical analysis showed enhanced expression of C-X-C chemokine receptor type 4 (CXCR4), the receptor of SDF-1, and of pERK in urothelial cells during BBN-induced bladder carcinogenesis. Finally, subcutaneous injection of CXCR4 antagonist, TF14016, attenuated pERK in urothelial cells and suppressed bladder carcinogenesis. These data indicate that TXNIP negatively regulates bladder carcinogenesis by attenuating SDF-1-CXCR4-induced ERK activation. This signal transduction pathway can be a potent target in preventing or treating bladder cancer.
AuthorsKoji Nishizawa, Hiroyuki Nishiyama, Yoshiyuki Matsui, Takashi Kobayashi, Ryoichi Saito, Hirokazu Kotani, Hiroshi Masutani, Shinya Oishi, Yoshinobu Toda, Nobutaka Fujii, Junji Yodoi, Osamu Ogawa
JournalCarcinogenesis (Carcinogenesis) Vol. 32 Issue 10 Pg. 1459-66 (Oct 2011) ISSN: 1460-2180 [Electronic] England
PMID21771725 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • CXCR4 protein, mouse
  • Carrier Proteins
  • Chemokine CXCL12
  • Cxcl12 protein, mouse
  • RNA, Messenger
  • Receptors, CXCR4
  • TXNIP protein, human
  • Txnip protein, mouse
  • Butylhydroxybutylnitrosamine
  • Thioredoxins
  • Extracellular Signal-Regulated MAP Kinases
Topics
  • Aged
  • Animals
  • Blotting, Western
  • Butylhydroxybutylnitrosamine (toxicity)
  • Carrier Proteins (genetics, metabolism, physiology)
  • Chemokine CXCL12 (genetics, metabolism)
  • Disease Models, Animal
  • Extracellular Signal-Regulated MAP Kinases (genetics, metabolism)
  • Female
  • Humans
  • Immunoenzyme Techniques
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Neoplasm Staging
  • Prognosis
  • RNA, Messenger (genetics)
  • Receptors, CXCR4 (antagonists & inhibitors, genetics, metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Signal Transduction
  • Survival Rate
  • Thioredoxins (metabolism, physiology)
  • Urinary Bladder Neoplasms (chemically induced, metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: